Literature DB >> 9605175

The effect of deletion of the V3 loop of gp120 on cytotoxic T cell responses and HIV gp120-mediated pathogenesis.

D Kmieciak1, T J Wasik, H Teppler, J Pientka, S H Hsu, H Takahashi, K Okumura, Y Kaneko, D Kozbor.   

Abstract

New strategies for improving the efficacy of HIV vaccines are of significant importance. In this study, we analyzed the effect of deletion of the hypervariable V3 loop of gp120 on envelope (env)-specific CTL responses in PBMC of HIV-infected individuals. We showed increased CTL activities against conserved epitopes of the env glycoprotein in cultures induced with the AV3 mutant compared with those stimulated with the full-length env gene products. In contrast to the wild-type env, the AV3 mutant-expressing cells were resistant to Ab-dependent cell-mediated cytotoxicity, formed no syncytia, and neither underwent nor induced apoptosis in CD4+ cells. Thus, the AV3 mutant may redirect immune responses toward conserved epitopes of gp160, has longer expression time due to increased resistance to Ab-dependent cell-mediated cytotoxicity, and does not trigger cytopathic effects associated with apoptosis and syncytium formation. This approach may apply to other Ags of HIV, where deletions of highly variable or immunosuppressive epitopes may improve the efficacy of HIV vaccines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605175

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Characterization of primary isolates of HIV type 1 CRF28_BF, CRF29_BF, and unique BF recombinants circulating in São Paulo, Brazil.

Authors:  Fernando Lucas Melo; Leda Fátima Jamal; Paolo Marinho de Andrade Zanotto
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-16       Impact factor: 2.205

2.  Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.

Authors:  Elizabeth Bolesta; Aleksandra Kowalczyk; Andrzej Wierzbicki; Cheryl Eppolito; Yutaro Kaneko; Masafumi Takiguchi; Leonidas Stamatatos; Protul A Shrikant; Danuta Kozbor
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

3.  Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses.

Authors:  Mohammed Asmal; Yue Sun; Sophie Lane; Wendy Yeh; Stephen D Schmidt; John R Mascola; Norman L Letvin
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

4.  Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.

Authors:  Irena Kiszka; Dariusz Kmieciak; Jaroslaw Gzyl; Toshio Naito; Elizabeth Bolesta; Aleksander Sieron; Satya P Singh; Alagarsamy Srinivasan; Giorgio Trinchieri; Yutaro Kaneko; Danuta Kozbor
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.

Authors:  Margaret Gil; Magdalena Bieniasz; Andrzej Wierzbicki; Barbara J Bambach; Hanna Rokita; Danuta Kozbor
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

Review 6.  HIV-1 gp120 binding to dendritic cell receptors mobilize the virus to the lymph nodes, but the induced IL-4 synthesis by FcepsilonRI+ hematopoietic cells damages the adaptive immunity--a review, hypothesis, and implications.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2004-08       Impact factor: 2.198

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.